Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imipenem-cilastatin.

M J Dinsmoor1

  • 1Department of Obstetrics and Gynecology, Medical College of Virginia, Virginia Commonwealth University, Richmond.

Obstetrics and Gynecology Clinics of North America
|September 1, 1992
PubMed
Summary

Imipenem-cilastatin is a safe antibiotic for obstetric and gynecologic infections, offering intramuscular options. However, its high cost and risk of resistance mean it

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In utero progression of mild fetal ventriculomegaly.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2006
Same author

Hepatitis C in pregnancy.

Current women's health reports·2002
Same author

Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001
Same author

Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.

Pediatrics·2000
Same author

Hepatitis in the obstetric patient.

Infectious disease clinics of North America·1997
Same author

Autologous blood donation with placenta previa: is it feasible?

American journal of perinatology·1995

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Pharmacology

Background:

  • Imipenem-cilastatin presents broad-spectrum antimicrobial activity.
  • It is considered relatively safe for patient use.
  • Intramuscular administration offers flexible treatment options.

Purpose of the Study:

  • To evaluate imipenem-cilastatin as a treatment for obstetric and gynecologic infections.
  • To discuss its potential role and limitations in clinical practice.

Main Methods:

  • Literature review of imipenem-cilastatin's efficacy and safety.
  • Analysis of its pharmacokinetic properties, including intramuscular administration.
  • Consideration of cost-effectiveness and antimicrobial resistance patterns.

Main Results:

  • Imipenem-cilastatin demonstrates broad-spectrum activity and safety in obstetric and gynecologic settings.
  • Intramuscular administration provides a viable alternative route.
  • High cost currently precludes its use as a first-line agent.

Conclusions:

  • Imipenem-cilastatin is a valuable therapeutic option for specific obstetric and gynecologic infections.
  • Judicious use is essential to mitigate the development of antibiotic resistance.
  • Ongoing surveillance of susceptibility patterns is crucial for effective antimicrobial stewardship.

Related Experiment Videos